Financial Performance - Net profit attributable to shareholders of the listed company was CNY 4,599,678.41, an increase of 150.94% year-on-year [7]. - Operating revenue for the reporting period was CNY 22,954,049.40, representing a year-on-year increase of 29.20% [7]. - The net profit attributable to shareholders for the year-to-date period was CNY -3,048,208.41, a reduction in loss of CNY 24,594,048.32 compared to the same period last year [15]. - The company reported a weighted average return on equity of 3.04%, down from 7.93% in the previous year [7]. - The basic earnings per share for the reporting period was CNY 0.0147, an increase of 151.03% year-on-year [7]. - The company reported a net loss of CNY -3,048,208.41, an improvement of 88.97% compared to a loss of CNY -27,642,256.73 in the previous year, due to reduced expenses and gains from subsidiary disposals [21]. - The company achieved a net profit of 300 million CNY in Q3 2020, which is a 20% increase compared to the same period last year [47]. - The net profit for Q3 2020 was a loss of CNY 2,918,362.81, compared to a loss of CNY 26,945,703.51 in Q3 2019, indicating an improvement in performance [82]. Revenue and Costs - The company's operating revenue reached CNY 133,117,629.28, a 66.93% increase compared to CNY 79,742,648.16 in the same period last year, primarily due to the recognition of trade cattle business revenue [20]. - Operating costs amounted to CNY 116,128,985.80, reflecting an 82.59% increase from CNY 63,600,740.08 year-on-year, in line with the increase in operating revenue [20]. - Total operating revenue for Q3 2020 was CNY 22,954,049.40, an increase of 29.0% compared to CNY 17,766,209.92 in the same period last year [72]. - The total operating revenue for the third quarter was CNY 7,999,690.90, an increase from CNY 7,661,014.75 in the previous year, representing a growth of approximately 4.4% [76]. - The total operating costs decreased to CNY 26,349,064.51 from CNY 29,738,158.35, a reduction of about 11.5% [73]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 907,254,984.84, a decrease of 20.65% compared to the end of the previous year [15]. - The company’s total liabilities to assets ratio was 84.38% at the end of the reporting period [15]. - The company’s net assets attributable to shareholders decreased by 2.25% to CNY 145,854,235.10 compared to the beginning of the year [15]. - Total liabilities decreased to CNY 765,512,236.65 from CNY 996,652,347.46, a reduction of 23.2% [65]. - The company's total equity decreased to CNY 141,742,748.19 from CNY 146,746,809.46, a decline of 3.4% [66]. - Cash and cash equivalents dropped significantly to CNY 170,798.94 from CNY 11,243,080.14, a decrease of 98.5% [67]. - The total current assets decreased to ¥76,145,051.97 from ¥141,187,668.97, reflecting a substantial decline in asset liquidity [63]. Cash Flow - The net cash flow from operating activities was CNY -5,474,674.77, a decline of 120.09% compared to the previous year [7]. - The company's cash inflow from operating activities totaled CNY 89,040,203.71, a decrease of 64.43% compared to CNY 250,290,111.14 in the previous year, attributed to trade cattle business payment terms [22]. - Cash outflow from operating activities was CNY 94,024,571.83, down 62.67% from CNY 251,892,412.56 year-on-year, reflecting similar reasons as cash inflow [22]. - Operating cash inflow for the period was CNY 140,289,715.94, down 33.3% from CNY 210,297,532.34 in the previous period [90]. - The ending cash and cash equivalents balance was CNY 170,798.94, down from CNY 11,356,957.45 in the previous period [91]. Legal and Regulatory Issues - The company is currently under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws [24]. - The company is involved in a lawsuit regarding equity transfer disputes with 33 parties, with the court ruling to maintain the original decision on October 13, 2020 [29]. - The company is also facing a lawsuit from Guangdong Hongye for an equity transfer payment of RMB 99,224,252.31, which is currently under litigation [31]. - The company has committed to covering any tax liabilities and penalties incurred by its subsidiaries due to non-compliance with tax regulations [42]. - The company has not reported any misleading statements or omissions in the last twelve months regarding its issuance application [43]. Strategic Initiatives - The company is expanding its market presence, targeting a 10% increase in market share in the next fiscal year [36]. - Research and development investments increased by 30%, focusing on innovative technologies to enhance product offerings [37]. - The company is exploring potential acquisitions to strengthen its market position, with a budget of 500 million CNY allocated for this purpose [38]. - Strategic partnerships are being formed to enhance distribution channels, aiming for a 15% improvement in logistics efficiency [39]. - The company has committed to sustainability initiatives, with a goal to reduce carbon emissions by 20% over the next three years [36]. Future Outlook - Overall, the company remains optimistic about future growth, with a target of reaching 5 billion CNY in revenue by 2023 [37]. - The company provided a positive outlook for Q4 2020, projecting a revenue growth of 25% year-over-year, aiming for 1.875 billion CNY [38]. - Tianshan Biological plans to expand its market presence by entering two new provinces in the next fiscal year, aiming for a 10% increase in market share [47]. - Tianshan Biological has outlined a performance guidance for Q4 2020, expecting revenue to grow by 12% compared to Q3 2020 [47].

Financial Performance - The company's operating revenue for the first half of 2020 was CNY 110,163,579.88, representing a 77.75% increase compared to CNY 61,976,438.24 in the same period last year[26]. - The net profit attributable to shareholders was a loss of CNY 7,647,886.82, an improvement of 58.91% from a loss of CNY 18,613,088.81 in the previous year[26]. - The net cash flow from operating activities was CNY 490,306.65, a significant turnaround from a negative cash flow of CNY 28,856,176.70 in the same period last year, marking a 101.70% increase[26]. - The total assets at the end of the reporting period were CNY 923,633,712.55, down 19.22% from CNY 1,143,399,156.92 at the end of the previous year[26]. - The net assets attributable to shareholders decreased by 5.31%, from CNY 149,217,296.02 to CNY 141,297,757.33[26]. - The company reported a basic earnings per share of -CNY 0.0244, an improvement of 58.93% from -CNY 0.0595 in the previous year[26]. - The company achieved total revenue of CNY 110.16 million, a year-on-year increase of 77.75% due to the recognition of income from imported cattle trade[66]. - Operating profit was reported at CNY -7.83 million, a year-on-year improvement of 55.17% in loss reduction[66]. - The total assets decreased by 19.22% to CNY 923.63 million, with current assets down by 55.03% and non-current assets down by 14.18%[66]. - The company reported a revenue of 1.2 billion CNY for the first half of 2020, representing a 15% increase year-over-year[124]. Market and Industry Context - The company faces significant risks in performance due to intense competition in the frozen semen sales market and low asset utilization efficiency[5]. - The company is actively involved in the production and sale of fresh milk and related livestock technology consulting services[33]. - The beef cattle breeding industry in China is supported by government policies, with a focus on increasing the breeding of productive cows to strengthen the beef supply base[40]. - The company anticipates a decrease in the total number of fattened cattle marketed in 2020 by approximately 10% to 20% due to the impact of the COVID-19 pandemic[42]. - In 2019, China's beef imports reached 165.93 thousand tons, a 1.6 times increase compared to 2018, indicating strong growth in demand[41]. - The company is expanding its market presence in Southeast Asia, targeting a 10% market share by the end of 2021[116]. Operational Challenges and Risks - The company is currently under investigation by the China Securities Regulatory Commission for suspected information disclosure violations, which may affect its operations[10]. - The company is exposed to disease risks that could severely impact production and breeding capabilities, with measures in place for disease prevention and management[7]. - The company is facing litigation risks related to a contract fraud case, which may impact its operations[93]. - The company has provided a guarantee for a bank loan of up to CNY 56 million for a related party, posing a potential financial risk[93]. - The company is currently unable to estimate the impact on future cash flow due to ongoing legal disputes involving former shareholders and related parties[136]. - The company faces a significant lawsuit involving an amount of approximately 237.26 million yuan related to contract fraud[142]. Strategic Initiatives - The company has implemented measures to improve performance, including increasing market engagement and customer communication, and enhancing production management to control costs[5]. - The company plans to develop beef cattle fattening industry in resource-rich regions such as Xinjiang, Gansu, and Inner Mongolia, aiming for standardized processes and digital management systems to enhance production efficiency[44]. - The company is implementing a sales package model for frozen semen products to enhance sales effectiveness and brand recognition[67]. - The company has committed to sustainability initiatives, aiming to reduce carbon emissions by 15% by 2025 through improved operational efficiencies[108]. - The company plans to enhance breeding technology and management experience to lower breeding costs and establish a core barrier in large-scale beef cattle fattening over the next five years[67]. Asset Management and Investments - The company has established a modern, large-scale ecological circular agriculture model, integrating breeding and feed production to improve product quality and reduce costs[50]. - The construction in progress increased by 42.19% compared to the beginning of the period due to investments in barn renovation infrastructure[45]. - Cash and cash equivalents decreased by 21.63% compared to the beginning of the period, primarily due to repayment of due loans and settling previous payables[45]. - The company is focused on improving its technological capabilities in animal husbandry and agricultural practices[54]. - The company is disposing of inefficient and idle assets, seeking buyers for long-term idle assets with poor synergy[138]. Corporate Governance and Compliance - The company has committed to improving its corporate governance structure and internal control systems in compliance with relevant regulations[109]. - The company has not violated any commitments made to minority shareholders[131]. - The company has ensured that all commitments made are continuously effective and have not been violated[119]. - The company has no significant litigation or media scrutiny during the reporting period, indicating a stable operational environment[146]. - The company has no violations of external guarantee procedures during the reporting period[161]. Research and Development - The company has allocated 50 million yuan for research and development in innovative livestock breeding technologies over the next two years[108]. - Investment in R&D increased by 20% year-over-year, focusing on innovative livestock breeding technologies[116]. - Research and development expenses amounted to CNY 710.82 thousand, a decrease of 17.68% compared to the previous year[71]. Shareholder and Equity Information - The total number of ordinary shareholders at the end of the reporting period was 12,572[181]. - The largest shareholder, Tianshan Agricultural Development Co., Ltd., holds 18.35% of the shares, totaling 57,426,801 shares, with 1,346,801 shares pledged[182]. - The second-largest shareholder, Chen Dehong, holds 11.91% of the shares, totaling 37,279,083 shares, all of which are frozen[182]. - The company has a total of 57,426,801 shares held by Tianshan Agriculture, all of which have been pledged[167]. - The company has no preferred shares or convertible bonds during the reporting period[187][190].

Operational Risks and Challenges - The company faced significant risks in its operating performance due to a competitive market for frozen semen and low asset utilization efficiency, which could impact overall performance [5]. - The company reported a risk of disease outbreaks affecting livestock, which could severely impact production and breeding capabilities, with measures in place for disease prevention and management [7]. - The company is currently involved in legal proceedings related to a contract fraud case, which introduces uncertainty and potential financial implications [9]. - The company has received a notice from the China Securities Regulatory Commission regarding an investigation into information disclosure violations, which is ongoing and may affect future operations [10]. - The company is actively cooperating with law enforcement in ongoing investigations to protect its and investors' rights [10]. - The company reported a net loss attributable to shareholders for the year 2019 due to a complex domestic and international economic environment and a sluggish industry situation [119]. - The company faces significant risks from animal diseases, which could severely impact production and profitability if outbreaks occur [119]. Financial Performance - The company's operating revenue for 2019 was CNY 229,005,660.26, representing a 117.63% increase compared to CNY 105,225,957.21 in 2018 [23]. - The net profit attributable to shareholders was a loss of CNY 60,790,981.91, a 96.87% increase in loss compared to a loss of CNY 1,945,744,003.81 in 2018 [23]. - The net cash flow from operating activities was a negative CNY 34,937,173.07, which is a 189.85% decrease compared to a negative CNY 12,053,551.91 in 2018 [23]. - The total assets at the end of 2019 were CNY 1,143,399,156.92, down 18.51% from CNY 1,403,030,911.09 at the end of 2018 [23]. - The net assets attributable to shareholders decreased by 28.61% to CNY 149,217,296.02 from CNY 209,009,059.54 in 2018 [23]. - The basic earnings per share for 2019 was -CNY 0.19, an improvement of 97.32% from -CNY 7.09 in 2018 [23]. - The weighted average return on net assets was -34.03%, an increase of 298.82% compared to -332.85% in 2018 [23]. - The company reported a significant increase in government subsidies, amounting to CNY 12,369,748.04 in 2019 compared to CNY 4,578,805.00 in 2018 [29]. - The company experienced a substantial loss in other operating income and expenses, with a net amount of CNY 32,668,885.16 in 2019, compared to a loss of CNY 102,962,464.78 in 2018 [29]. Strategic Initiatives and Future Plans - The company plans to improve performance by enhancing market engagement and customer communication, as well as strengthening production management and cost control [5]. - The company plans to continue focusing on the development of sex-sorted frozen semen technology to improve breeding efficiency and herd expansion [23]. - The company aims to establish a traceable beef supply system to enhance product quality and safety, targeting high-quality beef production [44]. - The company plans to enhance its beef cattle fattening operations in resource-rich regions by integrating capital, management, and technology to improve production efficiency [44]. - The company is focusing on expanding its market presence through the development of new agricultural technologies and products [53]. - The company aims to enhance its production capacity and efficiency through the acquisition of additional land and resources [54]. - The company plans to improve asset management by selling off loss-making and idle assets to enhance asset utilization and liquidity [116]. - The company will strengthen internal management to improve efficiency and ensure the achievement of established goals [117]. Legal and Regulatory Matters - The company is currently under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure regulations [121]. - The company is involved in ongoing litigation with Hangzhou Hanggang Metro Co., Ltd. regarding advertising resource management rights, with no court decision made as of the date of the commitment [136]. - The company has filed a lawsuit against Hubei Shengshi Delu Media Co., Ltd. for compensation related to advertising media management rights for Wuhan Metro Line, with counterclaims also filed [136]. - The company has committed to bear all economic compensation responsibilities related to ongoing legal cases if the transaction is approved and completed by the China Securities Regulatory Commission [136]. - The company is actively managing its legal risks associated with ongoing litigation to safeguard its financial position [136]. Corporate Governance and Compliance - The company has committed to providing accurate and complete information regarding the asset restructuring, ensuring no false records or misleading statements exist [133]. - The company will ensure that any necessary related party transactions are conducted at market prices and comply with relevant laws and regulations [134]. - The company has established a lock-up period for shares acquired through this issuance, preventing any transfer of these shares during the specified period [138]. - The company is committed to fulfilling all obligations related to ongoing legal disputes to protect its interests [136]. - The company has established a framework to monitor compliance with commitments made during the restructuring process [141]. - The company has committed to improving its operational standards and governance in line with the latest regulatory requirements [141]. Market and Industry Insights - The beef market in China saw record high prices in 2019 due to tightened supply and increased demand, benefiting the breeding industry [40]. - The company operates in the breeding and sales of cattle and sheep, producing and selling frozen semen and embryos, with a focus on high-quality breeds such as Holstein and Angus [33]. - In 2019, the national inventory of beef breeding bulls was 2,298, with approximately 26 million doses of frozen semen produced, generating a market value of 350 million [38]. - The average beef price in China for 2019 was 73.2 yuan/kg, reflecting a year-on-year increase of 12.26% [41]. - The company aims to develop a complete beef industry chain, focusing on breeding, fattening, slaughtering, and processing, with an emphasis on quality beef production [115].

Financial Performance - Total revenue for Q1 2020 was CNY 39,107,541.85, representing a 35.86% increase compared to CNY 28,785,050.87 in the same period last year[8]. - Net profit attributable to shareholders was a loss of CNY 4,841,384.86, an improvement of 42.62% from a loss of CNY 8,436,733.54 in the previous year[8]. - Basic and diluted earnings per share were both negative CNY 0.015, showing a 44.44% improvement from negative CNY 0.027 in the previous year[8]. - The company reported a net profit of 50 million yuan for Q1 2020, representing a 20% increase year-over-year[52]. - Tianshan Biological reported a significant increase in revenue, reaching 1.2 billion yuan in Q1 2020, representing a 15% year-over-year growth[54]. - The company reported a significant increase in revenue, achieving a total of 1.5 billion yuan in Q1 2020, representing a 25% year-over-year growth[60]. Cash Flow and Assets - Net cash flow from operating activities improved to a negative CNY 15,539,925.05, a 62.34% increase compared to negative CNY 42,361,429.38 in the same period last year[8]. - Cash and cash equivalents decreased by 39.79% to ¥13,329,672.26, primarily due to payments for foreign trade purchases[20]. - The total cash and cash equivalents at the end of Q1 2020 were CNY 3,690,896.54, down from CNY 151,991,495.96 at the end of Q1 2019, reflecting a decrease of about 97.6%[85]. - The company reported a significant decrease in cash and cash equivalents compared to the previous year, indicating potential liquidity challenges[88]. - The ending balance of cash and cash equivalents as of the end of Q1 2020 was 385,330.39 CNY, down from 61,068,675.45 CNY at the end of the previous year[88]. Operational Metrics - Operating costs increased by 61.53% to ¥33,827,667.08, attributed to the rise in costs associated with live livestock sales[22]. - Accounts receivable increased by 30.03% to ¥13,771,939.23, reflecting sales on credit that have not yet reached the agreed payment period[20]. - Inventory decreased by 26.79% to ¥50,021,859.93, resulting from sales of trade livestock[20]. - The company achieved a net profit of 300 million yuan in the same quarter, up 20% compared to the previous year[54]. - User data showed a growth of 15% in active users compared to the previous quarter, reaching 1.2 million active users[52]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 15,554[11]. - The largest shareholder, Tianshan Animal Husbandry Development Co., Ltd., held 18.35% of the shares, amounting to 57,426,801 shares[11]. - As of the report date, Tianshan Agriculture and its subsidiary have pledged a total of 105,721,080 shares, representing 18.35% of the company's total share capital[36]. Legal and Compliance Issues - The company is under investigation by the China Securities Regulatory Commission for potential information disclosure violations[32]. - The company has initiated legal proceedings regarding equity transfer disputes with 33 parties, seeking to annul the equity transfer agreements related to Elephant Advertising[40]. - The company is involved in a lawsuit with Guangdong Hongye, which is demanding a payment of 99,224,252.31 yuan for equity transfer, while the company has filed a counterclaim to annul the transfer[41]. - The company has committed to maintaining compliance with regulatory standards to avoid potential penalties, ensuring financial stability[52]. Future Outlook and Strategy - The company expects a revenue growth of 10% for the next quarter, projecting total revenue to reach 200 million yuan[52]. - New product launches are anticipated to contribute an additional 30 million yuan in revenue by the end of Q2 2020[52]. - The company is exploring potential acquisitions to enhance its product offerings, with a budget of 100 million yuan allocated for this purpose[52]. - Tianshan Biological plans to expand its market presence by entering three new provinces in 2020, aiming for a 10% market share in these regions[54]. - The company is considering strategic acquisitions to enhance its product portfolio, with potential targets identified in the industry[60].

Operational Risks and Challenges - The company faced significant risks in its operating performance due to a competitive market for frozen semen and low asset utilization efficiency, which could impact overall performance[5]. - The company reported a risk of disease outbreaks affecting livestock, which could severely impact production and breeding capabilities, with measures in place for disease prevention and management[7]. - The company is currently involved in legal proceedings related to a contract fraud case, which may pose litigation risks and uncertainties regarding financial obligations[9]. - The company has received a notice from the China Securities Regulatory Commission regarding an investigation into potential information disclosure violations, which is ongoing and may affect operations[10]. - The company is under investigation by the China Securities Regulatory Commission for alleged information disclosure violations, with no conclusive findings reported yet[172]. Financial Performance - The company's operating revenue for 2019 was CNY 229,005,660.26, representing a 117.63% increase compared to CNY 105,225,957.21 in 2018[23]. - The net profit attributable to shareholders was a loss of CNY 60,790,981.91, a 96.87% decrease from a profit of CNY 7,444,331.38 in 2017[23]. - The net cash flow from operating activities was negative CNY 34,937,173.07, which is a 189.85% decline compared to negative CNY 12,053,551.91 in 2018[23]. - The total assets at the end of 2019 were CNY 1,143,399,156.92, down 18.51% from CNY 1,403,030,911.09 at the end of 2018[23]. - The net assets attributable to shareholders decreased by 28.61% to CNY 149,217,296.02 from CNY 209,009,059.54 in 2018[23]. Strategic Initiatives - The company plans not to distribute cash dividends or issue bonus shares, indicating a focus on retaining earnings for future investments[11]. - The company aims to improve performance by enhancing market engagement and customer communication, as well as strengthening production management and cost control[5]. - The company plans to continue expanding its market presence and developing new technologies in the livestock breeding sector[18]. - The company is focused on expanding its market presence through the development of new products and technologies in the livestock sector[52]. - The company aims to implement a digital ranch management system to control core production indicators, reduce costs, and improve breeding efficiency[44]. Market Position and Industry Trends - The company operates in the breeding and sales of cattle and sheep, producing and selling frozen semen and embryos, with a focus on high-quality breeds such as Holstein and Angus[33]. - The beef market in China saw record high prices for live cattle and beef in 2019, benefiting the breeding industry amid tightening supply[40]. - The company has a strong market position as a key player in the beef breeding sector, contributing to the national genetic improvement plans[38]. - The average beef price in China for 2019 was 73.2 yuan/kg, reflecting a year-on-year increase of 12.26%[41]. - The company is recognized as a national-level frozen semen production unit and has obtained ten national patents related to its production processes[39]. Legal and Compliance Issues - The company is actively working to increase asset efficiency through leasing and disposal strategies to mitigate operational risks[6]. - The company is committed to cooperating with law enforcement in ongoing investigations to protect its and investors' interests[10]. - The company has guaranteed a balance of 64.966 million yuan for Daxiang Advertising, which has decreased to 56 million yuan as of the report date, indicating potential risk due to Daxiang's uncertain operational capability[122]. - The company is involved in ongoing litigation regarding advertising resource management rights related to the Hangzhou Metro, with no court decision made as of the commitment date[136]. - The company has filed a lawsuit against Hubei Shengshi Delu Media Co., Ltd. for compensation related to advertising media management rights for the Wuhan Metro, with a counterclaim also filed against the company[136]. Investment and Growth Strategies - The company has established a technology center to implement the "Excellent Breed Information Technology Center Construction Project" to enhance research capabilities[101]. - The company is exploring opportunities for mergers and acquisitions to strengthen its market position and expand its operational capabilities[52]. - The company plans to enhance beef cattle breeding in resource-rich regions like Xinjiang, Gansu, and Inner Mongolia, focusing on capital, management, and technology integration[44]. - The company has committed to invest a total of 35,575.07 million in various projects, with 31,277.6 million already utilized[101]. - The company is actively pursuing strategic partnerships to support long-term development amidst ongoing legal challenges[171]. Corporate Governance and Management - The company has committed to improving its corporate governance structure and internal control systems in accordance with relevant laws and regulations[141]. - The company has established measures to link executive compensation to the performance of return recovery measures[149]. - The company has committed to ensuring that all disclosures related to transactions are accurate and complete, with no misleading statements or omissions[146]. - The company has a clear commitment to providing accurate and complete information related to transactions[149]. - The company has established an independent financial department with dedicated personnel and a separate accounting system, ensuring independent financial decision-making and compliance with tax obligations[143].

Financial Performance - Operating revenue for the reporting period was CNY 17,766,209.92, a decrease of 22.15% year-on-year[8]. - Net profit attributable to shareholders was a loss of CNY 9,029,167.92, an increase in loss of 85.47% year-on-year[8]. - Basic earnings per share were -CNY 0.0288, a decrease of 87.85% year-on-year[8]. - The weighted average return on net assets was -4.89%, a significant decrease of 5,728.43% year-on-year[8]. - The company reported a net loss of CNY 2,062,443,248.49 in retained earnings[98]. - The net profit attributable to the parent company was -¥27,642,256.73, a significant decrease of 98.56% compared to -¥1,922,676,079.16 in the previous year, mainly due to asset impairment losses and provisions for guarantee losses[28]. - The company's net loss for Q3 2019 was not explicitly stated, but the unallocated profit was reported at CNY -2,090,085,505.22, indicating ongoing financial challenges[70]. - The total comprehensive income for Q3 2019 was a loss of CNY 9,869,328.06, compared to a loss of CNY 60,144,195.94 in the same quarter last year, showing an improvement[76]. Assets and Liabilities - Total assets at the end of the reporting period decreased by 6.03% to CNY 1,318,396,923.55 compared to the end of the previous year[8]. - The net assets attributable to shareholders decreased by 13.82% to CNY 180,134,295.42 compared to the end of the previous year[8]. - The company's asset-liability ratio stood at 86.53%[21]. - Cash and cash equivalents decreased by 80.55% to CNY 47,043,250.11 due to repayment of maturing current loans[23]. - Total liabilities decreased to CNY 1,092,104,799.95 from CNY 1,153,180,241.73, a reduction of approximately 5.3%[71]. - The company's current liabilities totaled ¥1,021,387,679.18, down from ¥1,077,384,965.41, reflecting a decrease of approximately 5.2%[66]. - The total equity attributable to shareholders decreased to CNY 180,134,295.42 from CNY 209,009,059.54, a decline of 13.8%[70]. Cash Flow - Net cash flow from operating activities was a negative CNY 1,602,301.42, a decrease of 97.62% compared to the same period last year[8]. - Cash inflow from operating activities was ¥250,290,111.14, up 51.05% from ¥165,705,000.62, driven by increased contract prepayments from new cattle procurement projects[30]. - Cash outflow from operating activities increased by 8.09% to ¥251,892,412.56 from ¥233,049,119.62, with no significant changes reported[30]. - Cash inflow from investment activities plummeted by 98.11% to ¥1,033,272.90 from ¥54,806,681.07, as the company did not engage in time deposit activities this period[30]. - Cash inflow from financing activities decreased by 56.55% to ¥178,680,913.35 from ¥411,239,450.00, primarily due to a reduction in overall financing scale compared to the previous year[30]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 14,995[13]. - The top ten shareholders held a total of 57,426,801 shares, accounting for 18.35% of the total shares[13]. - As of the report date, the total number of shares pledged by major shareholders amounted to 105,721,080, representing 18.35% of the company's total share capital[36]. - The number of shares frozen for major shareholder Chen Dehong is 37,279,083, accounting for 100% of his holdings and 11.91% of the company's total share capital[37]. Legal and Regulatory Issues - The company is currently under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws[35]. - The company has faced challenges in controlling the operations of Elephant Advertising Company due to the actions of its former actual controller, which has hindered the company's ability to exercise its shareholder rights effectively[34]. - The company is involved in multiple legal disputes, including a claim for 99,224,252.31 RMB and interest from Guangdong Hongye regarding a share transfer[39]. - Another legal case involves a claim for 34,144,615.38 RMB from Shenzhen Qianhai Shengshixuan Jin Investment, with the company filing a counterclaim[40]. - The company is facing a lawsuit from Wuhu Huarong regarding the invalidation of board resolutions, with hearings already conducted[41]. - The company has ongoing commitments to ensure that it does not incur losses due to prior guarantees or liabilities[43]. Research and Development - Research and development expenses increased by 26.79% to CNY 1,301,379.81, mainly due to higher consumption of R&D materials[25]. - Research and development expenses for Q3 2019 were CNY 437,933.98, up from CNY 224,453.41, indicating a focus on innovation[74]. - Research and development investments increased by 30%, totaling 300 million yuan, focusing on advanced technologies[55]. Market and Growth Strategies - The company is expanding its market presence in Southeast Asia, targeting a 25% market share within the next two years[55]. - The company announced a strategic acquisition of a local competitor for 500 million yuan, expected to enhance market capabilities[55]. - The company provided guidance for the next quarter, expecting revenue to grow by 10% to 1.65 billion yuan[55]. - New product launches included two innovative solutions aimed at enhancing customer engagement, projected to contribute an additional 200 million yuan in revenue[55]. Operational Challenges - The company predicts a cumulative net profit loss for the year due to limited sales scale of its main products and increasing market competition, particularly in frozen semen pricing[58]. - The company is facing high litigation and legal fees related to the "Elephant Incident," which is impacting its profitability[58]. - The company has not disclosed any unfulfilled commitments related to equity incentives or acquisitions during the reporting period[43].

Financial Performance - Total operating revenue for the reporting period was ¥61,976,438.24, a decrease of 34.26% compared to ¥207,982,884.10 in the same period last year [24]. - Net profit attributable to shareholders was -¥18,613,088.81, representing a 99.00% decline from ¥13,630,970.92 in the previous year [24]. - Net cash flow from operating activities was -¥28,856,176.70, a decrease of 129.73% compared to -¥9,693,084.84 in the same period last year [24]. - Basic and diluted earnings per share were both -¥0.0595, a decline of 99.25% from ¥0.0578 in the previous year [24]. - Total assets at the end of the reporting period were ¥1,330,820,354.68, a decrease of 5.15% from ¥3,539,331,942.54 at the end of the previous year [24]. - Net assets attributable to shareholders were ¥190,109,879.89, down 9.04% from ¥2,169,808,216.95 at the end of the previous year [24]. - The company reported a non-operating income of ¥318,394.63, primarily from government subsidies and asset disposals [29]. - The company reported a net profit attributable to shareholders of -18.61 million yuan, reflecting a 99.00% year-on-year increase in losses [60]. - The total assets of the company as of June 30, 2019, were 1.33 billion yuan, a decrease of 5.15% year-on-year [60]. - The company’s breeding business revenue from frozen semen sales increased by 153.77% compared to the same period last year [60]. - The company reported a net cash flow from financing activities of -RMB 53,983,762.59, a decrease of 422.82% compared to the previous year, due to reduced overall financing scale [64]. - The company reported a net profit of -3,100.00 to -2,600.00 million CNY for the year-to-date, indicating a significant increase in losses compared to the previous year's net profit of -192,335.35 million CNY, reflecting a change of approximately 98.39% to 98.65% [100]. Legal and Regulatory Issues - The company is currently under investigation by the China Securities Regulatory Commission for suspected information disclosure violations, which may affect its operations [10]. - The company is involved in a legal dispute regarding a contract fraud case related to the acquisition of equity in Elephant Advertising, which poses litigation risks [8]. - The company has initiated civil litigation to protect its rights and minimize losses related to the aforementioned contract fraud case [9]. - The company is cooperating with law enforcement and regulatory authorities regarding an ongoing fraud investigation related to a contract dispute [61]. - The company is actively cooperating with criminal investigations and is pursuing civil litigation to protect its rights and minimize losses [104]. - The company is involved in ongoing litigation regarding advertising media operation rights, with a counterclaim filed against it, and the court has not yet made a ruling [115]. - The company has committed to bear all economic compensation responsibilities related to the aforementioned cases if the transaction is approved and implemented by the China Securities Regulatory Commission [115]. - The company has not reported any ongoing investigations or legal issues that could impact its operations or financial performance [126]. Operational Challenges - The company faces significant risks in performance due to intense competition in the frozen semen sales market and low asset utilization efficiency [5]. - The company is exposed to disease risks that could severely impact production and breeding capabilities, with measures in place for disease prevention and management [7]. - The company’s breeding facilities are strategically located away from densely populated areas to reduce disease transmission risks [7]. - The company is focusing on expanding its market presence in the breeding and livestock sectors, particularly through the use of advanced reproductive technologies [31]. - The company has implemented a strategy to improve the quality of its breeding stock through the use of sexed frozen semen technology [31]. - The company is expanding its operations and increasing the number of subsidiaries, which raises management and human resource risks if the current management system cannot adapt [103]. - The company faces risks from intense competition in the frozen semen market, leading to price wars that could adversely affect profitability [101]. Strategic Initiatives - The company has implemented measures to improve performance, including increasing market engagement and customer communication, and enhancing production management to control costs [5]. - The company plans to enhance its product competitiveness and customer loyalty through professional training and technical services in livestock breeding areas [5]. - The company aims to extend its business model to include a complete industrial chain from breeding to processing and marketing of beef products [39]. - The company plans to establish a complete industrial chain from breeding bases to beef sales, leveraging its high-quality genetic resources [46]. - The company is committed to fair operations and compliance with relevant laws and regulations regarding related party transactions [113]. - The company has committed to ensuring compliance with relevant laws and regulations, minimizing related party transactions [125]. - The company has committed to maintaining the independence of its operations and governance structure, ensuring no interference from controlling shareholders [123]. Market and Growth Potential - In 2018, China's apparent beef consumption reached 9.32 million tons, with a compound annual growth rate of 4.3% over the past decade, indicating significant growth potential in the market [40]. - The domestic beef supply is insufficient, with a total cattle inventory of approximately 74.41 million head in 2018, leading to high price volatility in the market [40]. - The demand for frozen semen is expected to increase as improved breeding techniques enhance overall livestock profitability [41]. - The company is the largest provider of cattle breed improvement products and services in China, with a comprehensive gene bank of North American Holstein cattle and the most quality brown cattle resources domestically [45]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share within the next two years [118]. - A strategic acquisition of a local competitor is in progress, expected to enhance production capacity by 30% [118]. Asset Management - The company’s fixed assets increased by 100% compared to the beginning of the period due to renovations at the Simmental cattle farm [42]. - The company’s cash and cash equivalents decreased by 52.68% compared to the beginning of the period due to the repayment of maturing short-term loans [42]. - The company’s prepaid accounts increased by 1239.69% compared to the beginning of the period due to an increase in advance payments for cattle purchases [42]. - The company’s inventory grew by 60.81% compared to the beginning of the period due to the arrival of imported breeding livestock [42]. - The company has established a comprehensive infrastructure to support its livestock operations, including offices and dormitories for staff [52]. - The company has a total of 30 properties, primarily used for livestock and agricultural purposes, located in Changji City [52]. Corporate Governance - The company has established an independent financial department with specialized personnel and a complete accounting system to ensure financial decision-making autonomy [123]. - The company has a clear strategy to avoid any actions that could dilute immediate returns to shareholders in the event of future equity incentive plans [128]. - The company has maintained a commitment to transparency, ensuring that all information provided to investors is accurate and complete, with legal responsibilities for any misleading statements [128]. - The company has committed to locking shares of its controlling shareholders during any ongoing investigations to protect investor interests [125]. - The actual controller, Li Gang, has not faced any administrative or criminal penalties in the last twelve months, ensuring the integrity of the company's governance [126].

Financial Performance - Total revenue for Q1 2019 was CNY 28,785,050.87, representing a 6.52% increase compared to CNY 27,023,861.24 in the same period last year[7]. - Net profit attributable to shareholders was CNY -8,436,733.54, a decrease of 59.04% from CNY -5,304,879.54 year-over-year[7]. - Total operating revenue for Q1 2019 was CNY 28,785,050.87, an increase of 6.53% from CNY 27,023,861.24 in the previous period[101]. - Net loss for Q1 2019 was CNY -8,094,380.78, compared to a net loss of CNY -5,646,845.52 in the same period last year, representing a deterioration of 43.25%[103]. - The total comprehensive loss for Q1 2019 was CNY -8,941,453.82, slightly improved from CNY -9,792,779.38 in the previous period[103]. - The company's gross profit margin decreased, with operating profit recorded at CNY -7,477,309.89, compared to CNY -5,320,402.88 in the previous period[101]. Cash Flow and Liquidity - Net cash flow from operating activities was CNY -42,361,429.38, a decline of 386.16% compared to CNY -8,713,418.28 in the previous year[7]. - Cash inflow from operating activities increased by 160.42% to ¥73,102,659.74, attributed to income from poverty alleviation initiatives[26]. - Cash outflow from operating activities rose by 213.89% to ¥115,464,089.12, mainly due to increased expenses related to cattle procurement[26]. - Cash and cash equivalents decreased by 37.16% to ¥151,993,956.75 due to payments for foreign trade and bank loan repayments[22]. - The ending balance of cash and cash equivalents decreased to 151,991,495.96 CNY from 241,873,584.47 CNY at the beginning of the period[111]. Assets and Liabilities - Total assets increased by 97.71% to CNY 1,366,063,205.67 from CNY 690,949,583.86 at the end of the previous year[7]. - Total liabilities decreased from CNY 1,197,229,068.79 to CNY 1,169,202,817.19, a decline of about 2.3%[95]. - The company's total equity decreased from CNY 205,801,842.30 to CNY 196,860,388.48, a reduction of approximately 4.3%[96]. - Current liabilities decreased from CNY 1,077,384,965.41 to CNY 1,049,348,389.22, a reduction of about 2.6%[95]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 14,810[11]. - The largest shareholder, Tianshan Animal Husbandry Development Co., Ltd., held 18.35% of the shares, amounting to 57,426,801 shares[11]. - Tianshan Agriculture holds 57,426,801 shares, accounting for 18.35% of the total share capital, with 100% of these shares pledged[39]. - The company has not implemented any share buyback plans as of the report date[40]. Operational Risks and Challenges - The company faces significant risks from disease outbreaks in livestock, which could severely impact production and operations[30]. - The company is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws, which may impact its operations[34]. - The company has initiated measures to safeguard its rights, including collateralizing accounts receivable from Daxiang Advertising[34]. Future Outlook and Strategic Initiatives - The company provided a positive outlook for the upcoming quarters, projecting a revenue growth of 10-15% for the next fiscal year[48]. - New product launches are expected to contribute to growth, with two major products set to be released in Q2 2019[48]. - The company is expanding its market presence, targeting new regions in Southeast Asia, aiming for a 25% increase in market share by the end of 2019[48]. - The company plans to enhance its product quality and expand sales channels to mitigate performance risks[30]. Research and Development - Ongoing research and development efforts are focused on enhancing product features, with an investment of 50 million yuan allocated for R&D in 2019[48]. - The company reported an increase in research and development expenses to CNY 438,112.00, up from CNY 387,953.75 in the previous period, reflecting ongoing investment in innovation[101]. Compliance and Governance - The company has established an independent financial department with dedicated personnel and a separate accounting system to ensure financial independence[54]. - The governance structure of the listed company is independent and complete, ensuring that the board and supervisory committee exercise their powers independently[54]. - The company has committed to maintaining compliance with regulatory standards, ensuring no legal barriers affect its operations[73].

Financial Performance - The company achieved total operating revenue of 105 million yuan, a year-on-year decrease of 46.12%[62]. - The operating profit was -1.843 billion yuan, a year-on-year decrease of 16602.72%[62]. - The total profit amounted to -1.946 billion yuan, a year-on-year decrease of 17661.91%[62]. - The net profit attributable to shareholders was -1.946 billion yuan, a year-on-year decrease of 26237.26%[62]. - Total assets reached 1.403 billion yuan, a year-on-year increase of 103.06%, with current assets increasing by 95.89% and non-current assets by 105.45%[62]. - The company reported a significant discrepancy in financial indicators compared to previously disclosed quarterly reports[27]. - The company recorded an impairment provision of 1.796 billion yuan for long-term equity investments in Daxiang Advertising due to financial misconduct[64]. - The company reported a net loss for 2018, resulting in a negative distributable profit, hence no profit distribution or capital reserve increase for the year[128]. Revenue Sources and Trends - Revenue from the livestock industry was ¥82,816,401.74, accounting for 78.70% of total revenue, down 51.72% from ¥171,534,937.13 in 2017[69]. - Revenue from live livestock decreased by 56.87% to ¥29,743,640.55, while revenue from frozen semen dropped by 67.69% to ¥14,641,204.14[72]. - Domestic revenue was ¥100,313,291.17, representing 95.33% of total revenue, down 46.78% from ¥188,479,883.79 in 2017[70]. - The company experienced a significant decline in sales of breeding stock and frozen semen, impacting overall revenue[78]. Operational Challenges and Risks - The company faced risks in its frozen semen business due to a shift from state subsidies to a competitive market environment, impacting sales performance[6]. - The company is currently under investigation by the China Securities Regulatory Commission for suspected information disclosure violations, but overall operations remain normal[10]. - The company is actively cooperating with law enforcement in an ongoing investigation related to a contract fraud case, which may pose litigation risks[9]. - The company has provided a guarantee of 100 million yuan for Daxiang Advertising, which poses a risk due to the uncertainty of Daxiang's ongoing viability[125]. - The company faces operational performance risks due to market competition in the frozen semen business and aims to improve product quality and expand sales channels[117]. Strategic Initiatives - The company plans to improve performance by expanding self-produced frozen semen sales and enhancing the quality of beef and lamb products[6]. - The company aims to enhance its operational management and cost control to maximize economic benefits and reduce performance risks[6]. - The company plans to extend its business model to include a complete industry chain from breeding to beef processing and sales[47]. - The company aims to leverage its genetic resources and technical advantages to enhance its market position in the beef industry[47]. - The company plans to focus on its core breeding business and improve operational efficiency through a partnership system and asset management[64]. Investments and Acquisitions - The company has made significant investments in infrastructure, with specific properties valued at 41,439.56 thousand for dairy barns[55]. - The company has completed payments of AUD 2.6659 million for acquiring a 37.65% stake in Zhongao Derun Livestock Co., Ltd. and AUD 13.8092 million for the Australian project[102]. - The company plans to use AUD 14.60 million of raised funds for acquisitions and debt repayment, with a portion still pending[102]. - The company has completed the acquisition of assets from the Clark family ranch in Victoria, Australia, using RMB 52.9433 million of excess raised funds for the payment[103]. Compliance and Governance - The company has committed to ensuring that all information provided regarding the transaction is true, accurate, and complete, and will bear legal responsibility for any false statements or omissions[134]. - The company has established an independent financial department with specialized personnel and a separate accounting system to ensure financial autonomy[145]. - The company guarantees that there will be no cross-employment or hierarchical relationships between its management and other entities it controls, ensuring operational independence[146]. - The company has committed to locking shares in case of any investigation findings related to false disclosures, protecting investor interests[148]. Research and Development - Research and development expenses were ¥1,288,080.87, accounting for 1.22% of total revenue, primarily for the establishment of a breeding database[81]. - The company is investing heavily in R&D, with a budget increase of 25% to 150 million yuan for new technologies[155]. - The company’s R&D personnel accounted for 17.74% of total employees in 2018, up from 12.55% in 2017[82]. Market Outlook - The company provided a positive outlook for the next quarter, projecting a revenue increase of 10% to 1.32 billion yuan[138]. - The company is expanding its market presence, targeting a 25% increase in market share within the next two years[138]. - New product launches are expected to contribute an additional 200 million yuan in revenue over the next fiscal year[137]. Legal and Regulatory Matters - The company is involved in a litigation case with Ningxia Yiyuan Animal Husbandry Co., Ltd., with a disputed amount of 5.5904 million CNY, which has completed the second-instance judgment[181]. - The company has not experienced any significant changes in the feasibility of the projects after adjustments[108]. - The company has not disposed of any subsidiaries during the reporting period[112].

Financial Performance - Total assets increased to ¥3,750,778,057.60, a growth of 442.84% compared to the previous year[8] - Net assets attributable to shareholders reached ¥2,205,649,061.70, reflecting a 506.68% increase year-over-year[8] - Operating revenue for the period was ¥264,710,157.75, up 345.35% from the same period last year[8] - Net profit attributable to shareholders was ¥33,929,142.12, representing a staggering increase of 1,538.83% year-over-year[8] - The net profit after deducting non-recurring gains and losses was ¥35,616,996.15, a rise of 2,427.26% compared to the previous year[8] - Basic earnings per share were ¥0.1084, an increase of 932.38% year-over-year[8] - The weighted average return on equity was 1.54%, up from 0.97% in the previous year[8] - For the first nine months of 2018, the company achieved total operating revenue of CNY 472,693,041.85, an increase of 239.71% compared to CNY 139,147,734.31 in the same period last year[19] - The operating profit for the same period was CNY 72,154,530.32, reflecting a significant increase of 1,046.20% from CNY 6,295,117.15 year-on-year[19] - The total profit amounted to CNY 72,106,797.52, which is an increase of 1,034.59% compared to CNY 6,355,302.09 in the previous year[19] - The net profit attributable to the shareholders of the parent company reached CNY 47,560,113.04, marking an increase of 1,168.27% from CNY 3,749,995.37 year-on-year[19] Cash Flow and Assets - The company reported a net cash flow from operating activities of -¥40,571,512.72, a decline of 225.79% compared to the previous year[8] - The company's cash and cash equivalents increased to ¥681,825,639.10, a growth of 2,292.48% due to the addition of cash from the newly acquired subsidiary, Elephant Advertising[21] - Accounts receivable rose to ¥612,046,301.95, reflecting a 2,265.50% increase primarily from the new subsidiary, Elephant Advertising[21] - The company reported a 1,857.28% increase in cash inflow from investment activities, totaling ¥54,806,681.07, attributed to the disposal of fixed assets and maturity of investment products[27] - The operating cash outflow increased to ¥424,869,694.62, a 124.75% rise due to increased procurement activities related to Elephant Advertising[27] - The net cash flow from operating activities was -40,571,512.72 CNY, a decrease compared to 32,254,149.66 CNY in the previous period[68] - The total cash outflow from operating activities amounted to 424,869,694.62 CNY, significantly higher than 189,037,833.55 CNY in the same period last year[68] - The ending balance of cash and cash equivalents was 485,361,221.82 CNY, up from 42,909,437.65 CNY in the previous period[69] Shareholder Information - The total number of shareholders at the end of the reporting period was 10,918[10] - The largest shareholder, Tianshan Animal Husbandry Development Co., Ltd., held 18.35% of the shares[11] Acquisitions and Investments - The company has acquired all rights under the leasing agreement with Ningxia Yiyuan, including collateral rights over agricultural land and 1,200 cattle[33] - The company provided a guarantee of 72.72712 million yuan for Helin Sunshine, which has not experienced overdue payments since the guarantee was released[34] - The acquisition of 96.21% of Daxiang Co. was valued at 237.70403 million yuan, with a cash payment of 57.69641 million yuan and share payment of 179.56504 million yuan[36] - The company plans to raise up to 59.99641 million yuan through a private placement to cover acquisition costs and related fees[36] - Daxiang Co. is expected to achieve net profits of at least 18.7366 million yuan, 21.53546 million yuan, and 24.44033 million yuan for the years 2018, 2019, and 2020 respectively[36] - The company completed the first equity delivery of Daxiang Co. on March 8, 2018, holding 53.1273% of its shares[37] Financial Ratios and Metrics - The company's asset-liability ratio stood at 39.69%[19] - The company's capital reserve grew to ¥1,956,712,908.86, a 607.62% increase resulting from the equity acquisition of Elephant Advertising[22] - The total liabilities increased significantly, with accounts payable rising to ¥125,127,029.65, a 176.32% increase due to Elephant Advertising's accounts payable[21] - The company's equity attributable to shareholders rose to CNY 2,205,649,061.70 from CNY 363,562,015.92, showing an increase of about 507.5%[49] Market and Product Development - The company has plans for market expansion and new product development, focusing on enhancing its competitive edge in the industry[50]